Markus Dold
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Symptom networks in major depressive disorder and treatment response: special focus on TRD.
Journal: European psychiatry : the journal of the Association of European Psychiatrists
Published: May 27, 2025
The role of esketamine in persistent long COVID with predominant psychiatric manifestations.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: December 24, 2024
Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: November 07, 2024
Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials.
Journal: European psychiatry : the journal of the Association of European Psychiatrists
Published: March 01, 2024
The clinical perspective on late-onset depression in European real-world treatment settings.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: November 20, 2023
Age as a moderating factor of treatment resistance in depression.
Journal: European psychiatry : the journal of the Association of European Psychiatrists
Published: April 20, 2023
Silexan for treatment of anxiety and depression in the context of COVID-19.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: January 31, 2023
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder.
Journal: Journal of affective disorders
Published: January 05, 2023
Psychotherapy's Role for Treatment-Resistant Depression?
Journal: The American journal of psychiatry
Published: September 01, 2022
Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials.
Journal: European archives of psychiatry and clinical neuroscience
Published: July 07, 2022
Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited.
Journal: European archives of psychiatry and clinical neuroscience
Published: December 02, 2021
The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs.
Journal: Journal of affective disorders
Published: November 21, 2021
Last Updated: 09/26/2026